Comparative Safety Profiles of Oncology Biosimilars vs. Originators in Europe: An Analysis of the EudraVigilance Database

SIMPLE SUMMARY: Nowadays, biosimilar drugs are numerous and widely used in many clinical fields, including oncology. However, skepticism remains towards these products among doctors and patients, particularly regarding their safety profile compared to the reference products. This prompted this compa...

Descripción completa

Detalles Bibliográficos
Autores principales: Nikitina, Victoria, Santi Laurini, Greta, Montanaro, Nicola, Motola, Domenico
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10377930/
https://www.ncbi.nlm.nih.gov/pubmed/37509341
http://dx.doi.org/10.3390/cancers15143680

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10377930/
https://www.ncbi.nlm.nih.gov/pubmed/37509341
http://dx.doi.org/10.3390/cancers15143680

Ejemplares similares